rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomide
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03687957 |
|
Recruitment Status :
Recruiting
First Posted : September 27, 2018
Last Update Posted : May 18, 2023
|
Sponsor:
Washington University School of Medicine
Collaborators:
NeoImmuneTech
The Foundation for Barnes-Jewish Hospital
Information provided by (Responsible Party):
Washington University School of Medicine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 31, 2030 |
| Estimated Study Completion Date : | January 31, 2030 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):